Thanks again for the info! I'll have to look more at the Eye indications. Does the lack of a complete dose response cause you to be more cautious especially with your other point about placebo crossovers? I didn't see them listed in the JP Morgan agenda
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.